Vinpocetine (BioDeep_00000230020)

PANOMIX_OTCML-2023 Chemicals and Drugs

代谢物信息卡片

ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18),16-pentaene-17-carboxylate

化学式: C22H26N2O2 (350.1994176)
中文名称: 阿扑长春胺酸乙酯, 长春酸乙酯, 长春西丁, 长春西汀, 长春乙酯, 卡兰
谱图信息: 最多检出来源 Chinese Herbal Medicine(otcml) 1.08%

分子结构信息

SMILES: CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC
InChI: InChI=1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3

描述信息

Vinpocetine is an alkaloid. It has a role as a geroprotector.
Vinpocetine has been investigated for the treatment of Epilepsy.
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics
C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors
D002491 - Central Nervous System Agents > D018697 - Nootropic Agents
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids
C1907 - Drug, Natural Product
D020011 - Protective Agents
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.895
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.892
Vinpocetine (Ethyl apovincaminate) is a derivative of the alkaloid Vincamine that blocks voltage-gated Na+ channels. The IC50 value of Vinpocetine on direct IKK inhibition in the cell-free system is 17.17 μM. Vinpocetine is a phosphodiesterase (PDE) inhibitor and inhibits NF-κB-dependent inflammatory responses by directly targeting IκB kinase complex (IKK), and has been widely used for the treatment of cerebrovascular disorders[1][2][3].
Vinpocetine (Ethyl apovincaminate) is a derivative of the alkaloid Vincamine that blocks voltage-gated Na+ channels. The IC50 value of Vinpocetine on direct IKK inhibition in the cell-free system is 17.17 μM. Vinpocetine is a phosphodiesterase (PDE) inhibitor and inhibits NF-κB-dependent inflammatory responses by directly targeting IκB kinase complex (IKK), and has been widely used for the treatment of cerebrovascular disorders[1][2][3].

同义名列表

93 个代谢物同义名

ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18),16-pentaene-17-carboxylate; 11a-Ethyl-2,3,4,5,11a,11b-hexahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid 2-nitrooxy-ethyl ester(Vinpocetine); ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate; (41S,13aS)-ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; ethyl (41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; (41S,13aS)-ethyl13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate; ethyl(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate; (11aS,11bS)-11a-Ethyl-2,3,4,5,11a,11b-hexahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid ethyl ester; (3aS,11bS)-3a-ethyl-1,2,3,3a,10,11b-hexahydro-11H-5a,11a-diaza-benzo[cd]fluoranthene-5-carboxylic acid ethyl ester; Eburnamenine-14-carboxylic acid, ethyl ester, (3-alpha,16-alpha)-; Vinpocetine, United States Pharmacopeia (USP) Reference Standard; EBURNAMENINE 14-CARBOXYLIC ACID ETHYL ESTER (3.ALPHA.,16.ALPHA.); Eburnamenine-14-carboxylic acid, ethyl ester, (3alpha,16alpha)-; (3alpha, 16alpha)-Eburnamenine-14-carboxylic acid ethyl ester; Vinpocetine, European Pharmacopoeia (EP) Reference Standard; Eburnamenine-14-carboxylic acid, ethyl ester, (3a,16a)-; (3?,16?)-Eburnamenine-14-carboxylic acid ethyl ester; ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate; 3-alpha,16-alpha-Apovincaminic acid ethyl ester; ethyl apovincaminate, 2-oxopentanedioate (1:1); ethyl apovincaminate, (3alpha,16alpha)-isomer; Eburnamenine-14-carboxylic acid ethyl ester;; Eburnamenine-14-carboxylic acid ethyl ester; (3S,16S)-apovincaminic acid ethylester; ethyl apovincaminate, (16alpha)-isomer; (+)-cis-Apovincaminic acid ethyl ester; Vinpocetine 1.0 mg/ml in Acetonitrile; 3A,16A-Apovincaminic acid ethyl ester; ethyl apovincaminate tartrate (1:1); cis-Apovincaminic acid ethyl ester; (+)-Apovincaminic acid ethyl ester; ethyl apovincaminate, (+-)-isomer; Vinpocetine, analytical standard; ethyl apovincaminate, 3H-labeled; Vinpocetine-ethyl apovincaminate; Apovincaminate dethyle [French]; Vinpocetine [USAN:INN:BAN:JAN]; Apovincaminic acid ethyl ester; Ethyl (+)-cis-apovincaminate; DDNCQMVWWZOMLN-IRLDBZIGSA-N; Vinpocetine (JAN/USAN/INN); VINPOCETINE [EP MONOGRAPH]; Vinpocetine, >=98\\%, solid; Ethyl apovincamin-22-oate; Vinpocetinum [INN-Latin]; Ethyl (+)-apovincaminate; Apovincaminate dethyle; Vinpocetine (Cavinton); ethyl apovincaminate; VINPOCETINE [USP-RS]; VINPOCETINE [WHO-DD]; VINPOCETINE [MART.]; VINPOCETINE [VANDF]; VINPOCETINE [USAN]; VINPOCETINE [DSC]; Prestwick2_000268; VINPOCETINE [INN]; Prestwick3_000268; Vinpocetin- Bio-X; VINPOCETINE [JAN]; Prestwick1_000268; Prestwick0_000268; VINPOCETINE [MI]; Spectrum4_001075; Spectrum2_001529; Spectrum3_000961; Spectrum5_000966; Tox21_110648_1; Lopac0_001257; DivK1c_006423; BPBio1_000128; Tox21_501257; KBio2_001880; Tox21_110648; KBio2_004448; Tox21_110839; KBio3_001781; KBio2_007016; KBio1_001367; Vinpocetinum; Ultra-Vinca; Vinpocetine; Vinpocetin; AY-27,255; Bravinton; AY 27,255; Vinporal; Kavinton; Ceractin; Cavinton; TCV 3B; TCV-3B

数据库引用编号

19 个数据库交叉引用编号

ChEBI: CHEBI:32297
KEGGdrug: D01371
PubChem: 443955
Metlin: METLIN44335
DrugBank: DB12131
ChEMBL: CHEMBL71752
Wikipedia: Vinpocetine
MeSH: vinpocetine
ChemIDplus: 0042971095
chemspider: 392007
CAS: 115986-87-3
CAS: 68780-77-8
CAS: 42971-09-5
MoNA: BML82342
MoNA: BML82340
MoNA: BML00922
MoNA: BML00911
medchemexpress: HY-13295
MetaboLights: MTBLC32297

分类词条

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

3 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

文献列表

Zhang-Chao Dong, Yang Shi, Liang-Liang Zheng, You-Ping Tian, Jian Yang, Ying Wei, Ying Zhou, Bo-Wen Pan. Synthesis and Activity Evaluation of Vinpocetine-Derived Indole Alkaloids. Molecules (Basel, Switzerland). 2023 Dec; 29(1):. doi: 10.3390/molecules29010014. [PMID: 38202595]
Sumaia Abdulbari Ahmed Ali Hard, H N Shivakumar, Moqbel Ali Moqbel Redhwan. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine. International journal of biological macromolecules. 2023 Oct; ?(?):127217. doi: 10.1016/j.ijbiomac.2023.127217. [PMID: 37793522]
Hayder M Al-Kuraishy, Athanasios Alexiou, Marios Papadakis, Omnya Elhussieny, Hebatallah M Saad, Gaber El-Saber Batiha. New insights on the potential effect of vinpocetine in Parkinson's disease: one of the neglected warden and baffling topics. Metabolic brain disease. 2023 08; 38(6):1831-1840. doi: 10.1007/s11011-023-01254-y. [PMID: 37335452]
Archana Bharti Sonkar, Pranesh Kumar, Anand Kumar, Anurag Kumar Gautam, Abhishek Verma, Amita Singh, Umesh Kumar, Dinesh Kumar, Tarun Mahata, Bolay Bhattacharya, Amit K Keshari, Biswanath Maity, Sudipta Saha. Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines. International immunopharmacology. 2023 May; 119(?):110236. doi: 10.1016/j.intimp.2023.110236. [PMID: 37148772]
Hibah M Aldawsari, Shaimaa M Badr-Eldin, Nourah Y Assiri, Nabil A Alhakamy, Anna Privitera, Filippo Caraci, Giuseppe Caruso. Surface-tailoring of emulsomes for boosting brain delivery of vinpocetine via intranasal route: in vitro optimization and in vivo pharmacokinetic assessment. Drug delivery. 2022 Aug; 29(1):2671-2684. doi: 10.1080/10717544.2022.2110996. [PMID: 35975309]
Amany A Azouz, Fatema Hersi, Fares E M Ali, Asmaa M M Hussein Elkelawy, Hany A Omar. Renoprotective effect of vinpocetine against ischemia/reperfusion injury: Modulation of NADPH oxidase/Nrf2, IKKβ/NF-κB p65, and cleaved caspase-3 expressions. Journal of biochemical and molecular toxicology. 2022 Jul; 36(7):e23046. doi: 10.1002/jbt.23046. [PMID: 35315168]
Azza A Ali, Mona M Kamal, Mona G Khalil, Shimaa A Ali, Hemat A Elariny, Amany Bekhit, Ahmed Wahid. Behavioral, Biochemical and Histopathological effects of Standardised Pomegranate extract with Vinpocetine, Propolis or Cocoa in a rat model of Parkinson's disease. Experimental aging research. 2022 Mar; 48(2):191-210. doi: 10.1080/0361073x.2021.1959823. [PMID: 34384037]
Hyun Sik Kang, Jin Yong Song, Jong Heon Kim, Tae Il Park, Won Seok Choi, Ji -Yun Lee. Effects of vinpocetine on atopic dermatitis after administration via three different routes in HR-1 hairless mice. Die Pharmazie. 2022 01; 77(1):9-13. doi: 10.1691/ph.2022.1941. [PMID: 35045919]
Nasr Y Khalil, Ahmed H Bakheit, Hamad M Alkahtani, Turki Al-Muhanna. Vinpocetine (A comprehensive profile). Profiles of drug substances, excipients, and related methodology. 2022; 47(?):1-54. doi: 10.1016/bs.podrm.2021.10.001. [PMID: 35396012]
Shermineh Moini-Nodeh, Mahban Rahimifard, Maryam Baeeri, Mahshid Hodjat, Hamed Haghi-Aminjan, Mohammad Abdollahi. Vinpocetine Effect on the Juncture of Diabetes and Aging: An in-vitro study. Drug research. 2021 Oct; 71(8):438-447. doi: 10.1055/a-1381-6625. [PMID: 34255319]
Walaa Wadie, Nermeen S Abdel-Razek, Hesham A Salem. Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats. Life sciences. 2021 Jul; 277(?):119506. doi: 10.1016/j.lfs.2021.119506. [PMID: 33865881]
Esma Yıldırım, Gulay Sezer. Clinical plasma concentration of vinpocetine does not affect osteogenic differentiation of mesenchymal stem cells. Pharmacological reports : PR. 2021 Feb; 73(1):202-210. doi: 10.1007/s43440-020-00153-8. [PMID: 32865810]
Won Seok Choi, Hyun Sik Kang, Hong Jo Kim, Wang Tae Lee, Uy Dong Sohn, Ji-Yun Lee. Vinpocetine alleviates lung inflammation via macrophage inflammatory protein-1β inhibition in an ovalbumin-induced allergic asthma model. PloS one. 2021; 16(4):e0251012. doi: 10.1371/journal.pone.0251012. [PMID: 33914833]
Walaa Yehia Abdelzaher, Sabreen Mahmoud Ahmed, Nermeen N Welson, Najat Marraiki, Gaber El-Saber Batiha, Maha Yehia Kamel. Vinpocetine ameliorates L-arginine induced acute pancreatitis via Sirt1/Nrf2/TNF pathway and inhibition of oxidative stress, inflammation, and apoptosis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021 Jan; 133(?):110976. doi: 10.1016/j.biopha.2020.110976. [PMID: 33202281]
Ping Zhang, Yungang Cao, Songfang Chen, Liang Shao. Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury. Pharmacology. 2021; 106(1-2):37-44. doi: 10.1159/000506777. [PMID: 32294652]
I N Samartsev, S A Zhivolupov, J S Butakova, M S Parshin. [The open observational study of aceclofenac and vinpocetine effectiveness and tolerability in treatment of patients with chronic cerebrovascular disease after COVID-19 (AQUA study)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2021; 121(11):s1-s8. doi: 10.17116/jnevro2021121111s1. [PMID: 34968019]
Noha Nafee, Abd El Rahman Ameen, Osama Y Abdallah. Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400\% Brain Targeting Efficiency in Rats. AAPS PharmSciTech. 2020 Nov; 22(1):6. doi: 10.1208/s12249-020-01872-0. [PMID: 33222021]
Sally A Habib, Rehab S Abdelrahman, Mona Abdel Rahim, Ghada M Suddek. Anti-apoptotic effect of vinpocetine on cisplatin-induced hepatotoxicity in mice: The role of Annexin-V, Caspase-3, and Bax. Journal of biochemical and molecular toxicology. 2020 Oct; 34(10):e22555. doi: 10.1002/jbt.22555. [PMID: 32578916]
Qun Ma, Rui Luo, Huimin Zhang, Manman Dai, Luyu Bai, Qingsong Fei, Fang Lei, Ning He. Design, Characterization, and Application of a pH-Triggered In Situ Gel for Ocular Delivery of Vinpocetine. AAPS PharmSciTech. 2020 Sep; 21(7):253. doi: 10.1208/s12249-020-01791-0. [PMID: 32888086]
Ahsas Goyal, Debapriya Garabadu. Vinpocetine facilitates the anti-amnesic activity of estrogen-receptor alpha agonist in bilateral ovariectomy-challenged animals. Behavioural brain research. 2020 09; 393(?):112789. doi: 10.1016/j.bbr.2020.112789. [PMID: 32593544]
Wenjing Song, Weinan Yin, Liang Ding, Yang Gao, JingJing Xu, Yan Yang, Xin He, Pengju Gong, Lei Wei, Wenli Chen, Jingwei Zhang. Vinpocetine reduces cisplatin-induced acute kidney injury through inhibition of NF-κB pathway and activation of Nrf2/ARE pathway in rats. International urology and nephrology. 2020 Jul; 52(7):1389-1401. doi: 10.1007/s11255-020-02485-z. [PMID: 32418008]
Qun Ma, Manman Dai, Huimin Zhang, Luyu Bai, Ning He. Effect of different doses of borneol on the pharmacokinetics of vinpocetine in rat plasma and brain after intraocular administration. Xenobiotica; the fate of foreign compounds in biological systems. 2020 May; 50(5):580-587. doi: 10.1080/00498254.2019.1658139. [PMID: 31424307]
Jiaxin Zhou, Wenfang Zhang, Jiali Pang, Xiaoting Wang, Zijie Zheng, Yuanxin Li, Fan Yang, Wei Yang. Optimized preparation of vinpocetine micelles and in vivo evaluation of its pharmacokinetics in rats. Pharmaceutical development and technology. 2020 Apr; 25(4):464-471. doi: 10.1080/10837450.2019.1709501. [PMID: 31910066]
Meipeng Zhu, Hui Liu, Kai Sun, Jian Liu, Yan Mou, Dahu Qi, Chuankun Zhou, Maihaiti Abudunaibi, Bahebieergan Tasiken, Jianwen Li, Hao Cheng, Hui Huang. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020 Mar; 123(?):109769. doi: 10.1016/j.biopha.2019.109769. [PMID: 31846839]
Bo-Wen Pan, Yang Shi, Wen-Chao Li, Qing Wang, Meng Pan, Qiong Wu, Hong-Zheng Fu. Synthesis and biological evaluation of Vinpocetine derivatives. Bioorganic & medicinal chemistry letters. 2020 01; 30(2):126472. doi: 10.1016/j.bmcl.2019.05.052. [PMID: 31859156]
Jelena Ristic, Marko Folic, Katarina Radonjic, Milenko I Rosic, Sergey Bolevich, Omarov Israpil Alisultanovich, Nevena Draginic, Marijana Andjic, Jovana Jeremic, Isidora Milosavljevic, Vladimir Zivkovic, Vladimir Jakovljevic. Preconditioning with PDE1 Inhibitors and Moderate-Intensity Training Positively Affect Systemic Redox State of Rats. Oxidative medicine and cellular longevity. 2020; 2020(?):6361703. doi: 10.1155/2020/6361703. [PMID: 32104536]
Santoshi Billakota, J Michael Andresen, Bryant C Gay, Gregory R Stewart, Nikolai B Fedorov, Aaron C Gerlach, Orrin Devinsky. Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutation. Epilepsia. 2019 12; 60(12):2459-2465. doi: 10.1111/epi.16394. [PMID: 31755996]
Azza A Ali, Dina M Abo El-Ella, Soad Z El-Emam, Amal S Shahat, Rehab M El-Sayed. Physical & mental activities enhance the neuroprotective effect of vinpocetine & coenzyme Q10 combination against Alzheimer & bone remodeling in rats. Life sciences. 2019 Jul; 229(?):21-35. doi: 10.1016/j.lfs.2019.05.006. [PMID: 31063734]
Maha Nasr, Sara A Wahdan. Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration. Life sciences. 2019 Jun; 226(?):117-129. doi: 10.1016/j.lfs.2019.04.014. [PMID: 30981765]
Nam-Jun Kim, Jung-Hwan Baek, JinAh Lee, HyeNa Kim, Jun-Kyu Song, Kyung-Hee Chun. A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling. Experimental & molecular medicine. 2019 01; 51(1):1-15. doi: 10.1038/s12276-018-0198-7. [PMID: 30635550]
Zhang Ping, Wu Xiaomu, Xie Xufang, Shao Liang. Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2019 Jan; 40(1):113-120. doi: 10.1007/s10072-018-3592-y. [PMID: 30315378]
Tarek A Ahmed, Khalid M El-Say, Osama Aa Ahmed, Bader M Aljaeid. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel. International journal of nanomedicine. 2019; 14(?):5555-5567. doi: 10.2147/ijn.s213086. [PMID: 31413562]
Hebatalla I Ahmed, Somaia A Abdel-Sattar, Heba S Zaky. Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway. Naunyn-Schmiedeberg's archives of pharmacology. 2018 12; 391(12):1327-1338. doi: 10.1007/s00210-018-1552-y. [PMID: 30083945]
Cheng-Hwang Perng, Yue-Cune Chang, Ruu-Fen Tzang. The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis. Psychopharmacology. 2018 05; 235(5):1571-1580. doi: 10.1007/s00213-018-4867-y. [PMID: 29502274]
Suramya Waidyanatha, Heather Toy, Natalie South, Seth Gibbs, Esra Mutlu, Brian Burback, Barry S McIntyre, Natasha Catlin. Systemic exposure of vinpocetine in pregnant Sprague Dawley rats following repeated oral exposure: An investigation of fetal transfer. Toxicology and applied pharmacology. 2018 01; 338(?):83-92. doi: 10.1016/j.taap.2017.11.011. [PMID: 29155086]
Walaa Wadie, Dalia M El-Tanbouly. Vinpocetine mitigates proteinuria and podocytes injury in a rat model of diabetic nephropathy. European journal of pharmacology. 2017 Nov; 814(?):187-195. doi: 10.1016/j.ejphar.2017.08.027. [PMID: 28843828]
Mengqi Liu, Shiming Zhang, Shuxia Cui, Fen Chen, Lianqun Jia, Shu Wang, Xiumei Gai, Pingfei Li, Feifei Yang, Weisan Pan, Xinggang Yang. Preparation and evaluation of Vinpocetine self-emulsifying pH gradient release pellets. Drug delivery. 2017 Nov; 24(1):1598-1604. doi: 10.1080/10717544.2017.1388453. [PMID: 29043863]
Jiaojiao Ding, Yujiao Sun, Jinfeng Li, Huimin Wang, Shirui Mao. Enhanced blood-brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider. Journal of drug targeting. 2017 Jul; 25(6):532-540. doi: 10.1080/1061186x.2017.1289541. [PMID: 28151022]
Victor Fattori, Sergio M Borghi, Carla F S Guazelli, Andressa C Giroldo, Jefferson Crespigio, Allan J C Bussmann, Letícia Coelho-Silva, Natasha G Ludwig, Tânia L Mazzuco, Rubia Casagrande, Waldiceu A Verri. Vinpocetine reduces diclofenac-induced acute kidney injury through inhibition of oxidative stress, apoptosis, cytokine production, and NF-κB activation in mice. Pharmacological research. 2017 Jun; 120(?):10-22. doi: 10.1016/j.phrs.2016.12.039. [PMID: 28315429]
Mei-Ping Wu, Yi-Shuai Zhang, Xiangbin Xu, Qian Zhou, Jian-Dong Li, Chen Yan. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis. Cardiovascular drugs and therapy. 2017 Apr; 31(2):157-166. doi: 10.1007/s10557-017-6719-0. [PMID: 28321644]
Xungang Feng, Yuzhong Wang, Yanlei Hao, Qun Ma, Jun Dai, Zhibo Liang, Yantao Liu, Xiangyuan Li, Yan Song, Chuanping Si. Vinpocetine Inhibited the CpG Oligodeoxynucleotide-induced Immune Response in Plasmacytoid Dendritic Cells. Immunological investigations. 2017 Apr; 46(3):263-273. doi: 10.1080/08820139.2016.1248561. [PMID: 27967259]
Saylav Bora, Mumin Alper Erdogan, Güliz Armagan, Elvin Sevgili, Taner Dagcı. Vinpocetine and Vasoactive Intestinal Peptide Attenuate Manganese-Induced Toxicity in NE-4C Cells. Biological trace element research. 2016 Dec; 174(2):410-418. doi: 10.1007/s12011-016-0742-z. [PMID: 27206668]
Samuel Golob, Miranda Perry, Matteo Lusi, Michele R Chierotti, Iztok Grabnar, Lucia Lassiani, Dario Voinovich, Michael J Zaworotko. Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization. Journal of pharmaceutical sciences. 2016 12; 105(12):3626-3633. doi: 10.1016/j.xphs.2016.09.017. [PMID: 27789032]
Weiwei Zhang, Yining Huang, Ying Li, Liming Tan, Jianfei Nao, Hongtao Hu, Jingyu Zhang, Chen Li, Yuenan Kong, Yulin Song. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial. Clinical drug investigation. 2016 Sep; 36(9):697-704. doi: 10.1007/s40261-016-0415-x. [PMID: 27283947]
Ron Bonner, Gérard Hopfgartner. SWATH acquisition mode for drug metabolism and metabolomics investigations. Bioanalysis. 2016 Aug; 8(16):1735-50. doi: 10.4155/bio-2016-0141. [PMID: 27460983]
F Ghayomi, M Navaei-Nigjeh, M Baeeri, M A Rezvanfar, M Abdollahi. A mechanistic approach for modulation of chlorpyrifos-induced toxicity in human lymphocytes by melatonin, coenzyme Q10, and vinpocetine. Human & experimental toxicology. 2016 Aug; 35(8):839-50. doi: 10.1177/0960327115607945. [PMID: 26519479]
Patrizzia Mastromatteo-Alberga, Fabiola Placeres-Uray, Marcelo A Alfonzo-González, Ramona Gonzalez de Alfonzo, Itala Lippo de Becemberg, Marcelo J Alfonzo. A novel PDE1A coupled to M2AChR at plasma membranes from bovine tracheal smooth muscle. Journal of receptor and signal transduction research. 2016; 36(3):278-87. doi: 10.3109/10799893.2015.1101136. [PMID: 26513204]
Congcong Lin, Fen Chen, Tiantian Ye, Lina Zhang, Wenji Zhang, Dandan Liu, Wei Xiong, Xinggang Yang, Weisan Pan. A novel oral delivery system consisting in 'drug-in cyclodextrin-in nanostructured lipid carriers' for poorly water-soluble drug: vinpocetine. International journal of pharmaceutics. 2014 Apr; 465(1-2):90-6. doi: 10.1016/j.ijpharm.2014.02.013. [PMID: 24530388]
Hayder M Alkuraishy, Ali I Al-Gareeb, Ali K Albuhadilly. Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study. BioMed research international. 2014; 2014(?):324307. doi: 10.1155/2014/324307. [PMID: 25548768]
Hala Fahmy Zaki, Rania Mohsen Abdelsalam. Vinpocetine protects liver against ischemia-reperfusion injury. Canadian journal of physiology and pharmacology. 2013 Dec; 91(12):1064-70. doi: 10.1139/cjpp-2013-0097. [PMID: 24289077]
Yujun Cai, Jian-Dong Li, Chen Yan. Vinpocetine attenuates lipid accumulation and atherosclerosis formation. Biochemical and biophysical research communications. 2013 May; 434(3):439-43. doi: 10.1016/j.bbrc.2013.03.092. [PMID: 23583194]
Jianhui Zhuang, Wenhui Peng, Hailing Li, Yuyan Lu, Ke Wang, Fan Fan, Shuang Li, Yawei Xu. Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice. PloS one. 2013; 8(12):e82509. doi: 10.1371/journal.pone.0082509. [PMID: 24349299]
Nieves Herrera-Mundo, María Sitges. Vinpocetine and α-tocopherol prevent the increase in DA and oxidative stress induced by 3-NPA in striatum isolated nerve endings. Journal of neurochemistry. 2013 Jan; 124(2):233-40. doi: 10.1111/jnc.12082. [PMID: 23121080]
Rajendra S Kadam, David W A Bourne, Uday B Kompella. Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance. Drug metabolism and disposition: the biological fate of chemicals. 2012 Jul; 40(7):1380-8. doi: 10.1124/dmd.112.044925. [PMID: 22498894]
Gabriella Inczedy-Farkas, Viktoria Remenyi, Aniko Gal, Zsofia Varga, Petra Balla, Agnes Udvardy-Meszaros, Benjamin Bereznai, Maria Judit Molnar. Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behavioral and brain functions : BBF. 2012 Feb; 8(?):9. doi: 10.1186/1744-9081-8-9. [PMID: 22329956]
Chung-Hung Shih, Ling-Hung Lin, Hsin-Te Hsu, Kuo-Hsien Wang, Chi-Yin Lai, Chien-Ming Chen, Wun-Chang Ko. Hesperetin, a Selective Phosphodiesterase 4 Inhibitor, Effectively Suppresses Ovalbumin-Induced Airway Hyperresponsiveness without Influencing Xylazine/Ketamine-Induced Anesthesia. Evidence-based complementary and alternative medicine : eCAM. 2012; 2012(?):472897. doi: 10.1155/2012/472897. [PMID: 22454667]
Patrícia Severino, Tatiana Andreani, Ana Sofia Macedo, Joana F Fangueiro, Maria Helena A Santana, Amélia M Silva, Eliana B Souto. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. Journal of drug delivery. 2012; 2012(?):750891. doi: 10.1155/2012/750891. [PMID: 22175030]
You-Lan Yang, Hsin-Te Hsu, Kuo-Hsien Wang, Cheng-Ying Han, Chien-Ming Chen, Chi-Ming Chen, Wun-Chang Ko. Hesperetin-7,3'-O-dimethylether selectively inhibits phosphodiesterase 4 and effectively suppresses ovalbumin-induced airway hyperresponsiveness with a high therapeutic ratio. Journal of biomedical science. 2011 Nov; 18(?):84. doi: 10.1186/1423-0127-18-84. [PMID: 22074248]
Omar M E Abdel-Salam, Yasser A Khadrawy, Neveen A Salem, Amany A Sleem. Oxidative stress in a model of toxic demyelination in rat brain: the effect of piracetam and vinpocetine. Neurochemical research. 2011 Jun; 36(6):1062-72. doi: 10.1007/s11064-011-0450-1. [PMID: 21448596]
R Holy, M Navara, P Dosel, P Fundova, P Prazenica, A Hahn. Hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss (ISSNHL) in association with combined treatment. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 2011 Mar; 38(2):137-42. doi: NULL. [PMID: 21510273]
Alexei V Muravyov, Svetlana V Bulaeva, Irina A Tikhomirova, Andrey V Zamishlayev, Ekaterina V Uzikova, Mikhail Ju Miloradov. Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: the molecular change mechanisms after pentoxifylline treatment. Clinical hemorheology and microcirculation. 2011; 49(1-4):431-9. doi: 10.3233/ch-2011-1493. [PMID: 22214714]
Meiying Ning, Yue Zhou, Guojun Chen, Xingguo Mei. Preparation and in vitro/in vivo evaluation of vinpocetine elementary osmotic pump system. Advances in pharmacological sciences. 2011; 2011(?):385469. doi: 10.1155/2011/385469. [PMID: 21577257]
Chung-Hung Shih, Tzu-Jung Huang, Chien-Ming Chen, Yun-Lian Lin, Wun-Chang Ko. S-Petasin, the Main Sesquiterpene of Petasites formosanus, Inhibits Phosphodiesterase Activity and Suppresses Ovalbumin-Induced Airway Hyperresponsiveness. Evidence-based complementary and alternative medicine : eCAM. 2011; 2011(?):132374. doi: 10.1093/ecam/nep088. [PMID: 19641087]
Yosra S R Elnaggar, Magda A El-Massik, Ossama Y Abdallah. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. International journal of nanomedicine. 2011; 6(?):3195-205. doi: 10.2147/ijn.s25825. [PMID: 22238508]
Hui-Min Xia, Li-Na Su, Jian-Wei Guo, Guang-Ming Liu, Zhi-Qing Pang, Xin-Guo Jiang, Jun Chen. Determination of vinpocetine and its primary metabolite, apovincaminic acid, in rat plasma by liquid chromatography-tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2010 Jul; 878(22):1959-66. doi: 10.1016/j.jchromb.2010.05.029. [PMID: 20561830]
Chun-Yang Zhuang, Ning Li, Mi Wang, Xiao-Ning Zhang, Wei-San Pan, Jun-Jie Peng, Yu-Sheng Pan, Xin Tang. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. International journal of pharmaceutics. 2010 Jul; 394(1-2):179-85. doi: 10.1016/j.ijpharm.2010.05.005. [PMID: 20471464]
Hongtao Xu, Ling He, Shufang Nie, Jin Guan, Xiaoning Zhang, Xinggang Yang, Weisan Pan. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. Journal of controlled release : official journal of the Controlled Release Society. 2009 Nov; 140(1):61-8. doi: 10.1016/j.jconrel.2009.07.014. [PMID: 19651165]
A A Vishnevskiĭ, I G Korotkevich, Ch O Zhaparalieva. [Membrane and functional effects of vinpocetine and tocopherol in rats with experimental cerebral ischemia]. Biomeditsinskaia khimiia. 2009 Sep; 55(5):635-42. doi: NULL. [PMID: 20017394]
Gergely Feher, Katalin Koltai, Gabor Kesmarky, Beata Horvath, Kalman Toth, Samuel Komoly, Laszlo Szapary. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2009 Mar; 16(2-3):111-7. doi: 10.1016/j.phymed.2008.10.014. [PMID: 19135345]
Amr Mohamed Beltagi. Development and validation of an adsorptive stripping voltammetric method for the quantification of vincamine in its formulations and human serum using a Nujol-based carbon paste electrode. Chemical & pharmaceutical bulletin. 2008 Dec; 56(12):1651-7. doi: 10.1248/cpb.56.1651. [PMID: 19043234]
Jizhong Li, Fei Chen, Chanjuan Hu, Ling He, Keshu Yan, Liying Zhou, Weisan Pan. Optimized preparation of in situ forming microparticles for the parenteral delivery of vinpocetine. Chemical & pharmaceutical bulletin. 2008 Jun; 56(6):796-801. doi: 10.1248/cpb.56.796. [PMID: 18520083]
András Nemes, László Czibula, Csaba Szántay, Anikó Gere, Béla Kiss, Judit Laszy, István Gyertyán, Zsolt Szombathelyi, Csaba Szántay. Synthesis and evaluation of 2'-hydroxyethyl trans-apovincaminate derivatives as antioxidant and cognitive enhancer agents. Journal of medicinal chemistry. 2008 Feb; 51(3):479-86. doi: 10.1021/jm070618k. [PMID: 18183943]
Bharti Sapra, Subheet Jain, A K Tiwary. Percutaneous permeation enhancement by terpenes: mechanistic view. The AAPS journal. 2008; 10(1):120-32. doi: 10.1208/s12248-008-9012-0. [PMID: 18446512]
Ales Hahn, Lenka Radkova, Gabriela Achiemere, Vladislav Klement, Dario Alpini, Jaroslav Strouhal. Multimodal therapy for chronic tinnitus. The international tinnitus journal. 2008; 14(1):69-72. doi: ". [PMID: 18616089]
Laura S S Ribeiro, Amílcar C Falcão, João A B Patrício, Domingos C Ferreira, Francisco J B Veiga. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine. Journal of pharmaceutical sciences. 2007 Aug; 96(8):2018-28. doi: 10.1002/jps.20294. [PMID: 17530626]
V A Nevzorova, N V Zakharchuk, I V Plotnikova. [The state of cerebral blood flow in hypertensive crises and possibilities of its correction]. Kardiologiia. 2007; 47(12):20-3. doi: NULL. [PMID: 18260974]
B S Nayak, Lexley M Pinto Pereira. Catharanthus roseus flower extract has wound-healing activity in Sprague Dawley rats. BMC complementary and alternative medicine. 2006 Dec; 6(?):41. doi: 10.1186/1472-6882-6-41. [PMID: 17184528]
F Cervenka, L Jahodár. [Plant metabolites as nootropics and cognitives]. Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. 2006 Sep; 55(5):219-29. doi: ". [PMID: 17128592]
YiFan Luo, DaWei Chen, LiXiang Ren, XiuLi Zhao, Jing Qin. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. Journal of controlled release : official journal of the Controlled Release Society. 2006 Aug; 114(1):53-9. doi: 10.1016/j.jconrel.2006.05.010. [PMID: 16828192]
Shahin Akhondzadeh, Seyed Hesameddin Abbasi. Herbal medicine in the treatment of Alzheimer's disease. American journal of Alzheimer's disease and other dementias. 2006 Mar; 21(2):113-8. doi: 10.1177/153331750602100211. [PMID: 16634467]
Laurian Vlase, Silvia Imre, Sorin Leucuta. New HPLC-MS method for quantitative determination of apovincaminic acid in human plasma. Journal of separation science. 2006 Feb; 29(3):385-9. doi: 10.1002/jssc.200500284. [PMID: 16544880]
Jun Chen, Jia Cai, Weixing Tao, Ni Mei, Shilei Cao, Xinguo Jiang. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2006 Jan; 830(2):201-6. doi: 10.1016/j.jchromb.2005.10.052. [PMID: 16321580]
Adám Vas, Balázs Gulyás. Eburnamine derivatives and the brain. Medicinal research reviews. 2005 Nov; 25(6):737-57. doi: 10.1002/med.20043. [PMID: 16158388]
Laurian Vlase, Bogdan Bodiu, Sorin E Leucuta. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter. Arzneimittel-Forschung. 2005; 55(11):664-8. doi: 10.1055/s-0031-1296915. [PMID: 16366040]
Maximiliano A D'Angelo, Santiago Sanguineti, Jeffrey M Reece, Lutz Birnbaumer, Héctor N Torres, Mirtha M Flawiá. Identification, characterization and subcellular localization of TcPDE1, a novel cAMP-specific phosphodiesterase from Trypanosoma cruzi. The Biochemical journal. 2004 Feb; 378(Pt 1):63-72. doi: 10.1042/bj20031147. [PMID: 14556647]
Adám Vas, Halldin Christer, Judit Sóvágó, Sandell Johan, Zsolt Cselényi, Béla Kiss, Egon Kárpáti, Farde Lars, Balázs Gulyás. [Human positron emission tomography with oral 11C-vinpocetine]. Orvosi hetilap. 2003 Nov; 144(46):2271-6. doi: NULL. [PMID: 14702922]
László Szapáry, Beáta Horváth, Tamás Alexy, Zsolt Márton, Gábor Késmárky, Mónika Szóts, Ferenc Nagy, József Czopf, Kálmán Tóth. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease]. Orvosi hetilap. 2003 May; 144(20):973-8. doi: NULL. [PMID: 12830727]
Paul E Gold, Larry Cahill, Gary L Wenk. The lowdown on Ginkgo biloba. Scientific American. 2003 Apr; 288(4):86-91. doi: 10.1038/scientificamerican0403-86. [PMID: 12661320]
Kenjiro Noyama, Shohei Maekawa. Localization of cyclic nucleotide phosphodiesterase 2 in the brain-derived Triton-insoluble low-density fraction (raft). Neuroscience research. 2003 Feb; 45(2):141-8. doi: 10.1016/s0168-0102(02)00208-0. [PMID: 12573460]
B Gulyás, C Halldin, J Sandell, P Karlsson, J Sóvágó, E Kárpáti, B Kiss, A Vas, Z Cselényi, L Farde. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta neurologica Scandinavica. 2002 Dec; 106(6):325-32. doi: 10.1034/j.1600-0404.2002.01302.x. [PMID: 12460136]
Balázs Gulyás, Christer Halldin, Judit Sóvágó, Johan Sandell, Zsolt Cselényi, Adám Vas, Béla Kiss, Egon Kárpáti, Lars Farde. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine. European journal of nuclear medicine and molecular imaging. 2002 Aug; 29(8):1031-8. doi: 10.1007/s00259-002-0823-4. [PMID: 12173017]
Beáta Horváth, Zsolt Márton, Róbert Halmosi, Tamás Alexy, László Szapáry, Judit Vékási, Zsolt Bíró, Tamás Habon, Gábor Késmárky, Kálmán Tóth. [Scavenger effect of various cerebrovascular drugs]. Orvosi hetilap. 2002 Jan; 143(1):13-7. doi: NULL. [PMID: 11816373]
A Robichaud, C Savoie, P B Stamatiou, N Lachance, P Jolicoeur, R Rasori, C C Chan. Assessing the emetic potential of PDE4 inhibitors in rats. British journal of pharmacology. 2002 Jan; 135(1):113-8. doi: 10.1038/sj.bjp.0704457. [PMID: 11786486]
Beata Horvath, Zsolt Marton, Robert Halmosi, Tamas Alexy, Laszlo Szapary, Judit Vekasi, Zsolt Biro, Tamas Habon, Gabor Kesmarky, Kalman Toth. In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine. Clinical neuropharmacology. 2002 Jan; 25(1):37-42. doi: 10.1097/00002826-200201000-00007. [PMID: 11852295]
S Uckert, A Küthe, U Jonas, C G Stief. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. The Journal of urology. 2001 Dec; 166(6):2484-90. doi: . [PMID: 11696815]
T Szakács, Z Veres, L Vereczkey. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine. Polish journal of pharmacology. 2001 Nov; 53(6):623-8. doi: NULL. [PMID: 11985336]
F Trejo, V Nekrassov, M Sitges. Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings. Brain research. 2001 Aug; 909(1-2):59-67. doi: 10.1016/s0006-8993(01)02621-x. [PMID: 11478921]
G Kolarov, M Orbetsova, B Nalbanski, Z Kamenov, S Georgiev, E Filipov, Iu Petrova, B Marinov, G Georgiev. [Complex effects of cavinton on climacteric symptoms]. Akusherstvo i ginekologiia. 2001; 42(2):37-41. doi: 10.3201/eid0801.010149. [PMID: 11799757]
R I Westphalen, A Stadlin. Dopamine uptake blockers nullify methamphetamine-induced decrease in dopamine uptake and plasma membrane potential in rat striatal synaptosomes. Annals of the New York Academy of Sciences. 2000 Sep; 914(?):187-93. doi: 10.1111/j.1749-6632.2000.tb05195.x. [PMID: 11085320]